In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

WuXi AppTec closes RMB2.3bn IPO on Shanghai Stock Exchange

Executive Summary

WuXi AppTec Inc. (contract drug discovery and cGMP manufacturing services) grossed RMB21.60 ($354mm) in an initial public offering of 104mm shares at RMB21.60 on the Shanghai Stock Exchange.
Deal Industry
  • Biotechnology
  • Contract Research, Toxicology Testing-CRO
  • Medical Devices
  • Pharmaceuticals
  • Services
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register